{"id":14205,"date":"2024-10-13T07:00:00","date_gmt":"2024-10-13T07:00:00","guid":{"rendered":"https:\/\/eunewsroom.com\/fecal-microbiota-transplantation-fmt-market-is-expected-to-reach-us-1-83-bn-by-2030-as-per-maximize-market-research\/"},"modified":"2024-10-13T07:00:00","modified_gmt":"2024-10-13T07:00:00","slug":"fecal-microbiota-transplantation-fmt-market-is-expected-to-reach-us-1-83-bn-by-2030-as-per-maximize-market-research","status":"publish","type":"post","link":"https:\/\/eunewsroom.com\/en\/fecal-microbiota-transplantation-fmt-market-is-expected-to-reach-us-1-83-bn-by-2030-as-per-maximize-market-research\/","title":{"rendered":"Fecal Microbiota Transplantation (FMT) Market is expected to reach US$ 1.83 Bn. by 2030, as per Maximize Market Research"},"content":{"rendered":"


\n<\/p>\n

(EMAILWIRE.COM<\/a>, October 13, 2024 ) Fecal Microbiota Transplantation (FMT) Market Dynamics<\/p>\n

FMT market refers to transferring of healthy persons gut microbes to a patients in order to cure disease. <\/p>\n

North America is expected to dominate the global market. The Clostridium difficile infection (CDI) is a leading cause of nosocomial infection in the United States. This has significant risk of morbidity and mortality. This is expected to drive the North American market for FMT further during the forecast period.<\/p>\n

To access more comprehensive information, click here: https:\/\/www.maximizemarketresearch.com\/request-sample\/91371\/<\/a> <\/p>\n

Recent News<\/p>\n

1\/10\/2024 Fecal Microbiota Transplantation Boosts Response to Pembrolizumab Plus Axitinib in mRCC<\/p>\n

23\/1\/2024 Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury<\/p>\n

8\/4\/2024 Transplantation of gut microbiota derived from patients with schizophrenia induces schizophrenia-like behaviors and dysregulated brain transcript response in mice<\/p>\n

Fecal Microbiota Transplantation (FMT) Market Segment Analysis<\/p>\n

by Disease Indication<\/p>\n

Clostridium Difficile Infections

\nParkinsons Disease

\nObesity

\nDiabetes Mellitus

\nAutism

\nOthers<\/p>\n

To access more comprehensive information, click here: https:\/\/www.maximizemarketresearch.com\/request-sample\/91371\/<\/a> <\/p>\n

Fecal Microbiota Transplantation (FMT) Market, Key Players<\/p>\n

Rebiotix Inc.

\nFinch Therapeutics

\nSeres Therapeutics

\nCrestovo LLC

\nMicroBiome Therapeutics LLC<\/p>\n

To access more comprehensive information, click here: https:\/\/www.maximizemarketresearch.com\/request-sample\/91371\/<\/a> <\/p>\n

Related Reports<\/p>\n

The Xenotransplantation Market<\/a> size was valued at USD 13.8 billion in 2023 and is expected to reach USD 25.2 billion by 2030, at a CAGR of 8.94%.<\/p>\n

The Tongue Depressors Market<\/a> size was valued at USD 236.4 million in 2023 and the total tongue depressors market revenue is expected to grow at a CAGR of 3.40% from 2024 to 2030, reaching nearly USD 291.5 million by 2030.<\/p>\n

The Virtual Hospital Market<\/a> was valued at USD 11.05 billion in 2023, and its total revenue is expected to grow at a CAGR of 31.5 % from 2024 to 2030, reaching nearly USD 75.40 billion by 2030.<\/p>\n

About Maximize<\/p>\n

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.<\/p>\n<\/div>\n


\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

(EMAILWIRE.COM, October 13, 2024 ) Fecal Microbiota Transplantation (FMT) Market Dynamics FMT market refers to transferring of healthy persons gut microbes to a patients in order to cure disease. North America is expected to dominate the global market. The Clostridium difficile infection (CDI) is a leading cause of nosocomial infection in the United States. This […]<\/p>\n","protected":false},"author":1,"featured_media":3786,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1150,185],"tags":[],"class_list":{"0":"post-14205","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-press-releases-fr","8":"category-press-releases"},"_links":{"self":[{"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/posts\/14205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/comments?post=14205"}],"version-history":[{"count":0,"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/posts\/14205\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/media\/3786"}],"wp:attachment":[{"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/media?parent=14205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/categories?post=14205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eunewsroom.com\/en\/wp-json\/wp\/v2\/tags?post=14205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}